I. Introduction
Breast cancer continues to be a leading cause of death in western countries and yet the most common cancer in women worldwide, comprising 16% of all female cancers. It is estimated that 519,000 women died in 2004 due to breast cancer (WHO Global Burden of Disease, 2004). Breast cancer survival rates vary greatly worldwide, ranging from 80% or over in North America, Sweden and Japan to around 60% in middle-income countries and below 40% in low-income countries (Coleman et al., 2008). The prognostic for women diagnosed with the disease is greatly influenced by the stage at which it is discovered. Long term survival is significantly improved for women found with small tumors in the early stages of development.